| PYQ Relevance[UPSC 2020] COVID-19 pandemic has caused unprecedented devastation worldwide. However, technological advancements are being availed readily to win over the crisis. Give an account of how technology was sought to aid management to the pandemic.Linkage: This PYQ tests application of technology in public health crises, focusing on diagnostics, digital tools, and governance outcomes in disease management. The same COVID-driven technological shift (AI, rapid diagnostics, decentralisation) is now being institutionalised in TB control to address early detection gaps and improve accessibility. |
Mentor’s Comment
India’s fight against tuberculosis (TB) is entering a decisive phase. On the occasion of World TB Day (March 24), the focus has shifted from treatment expansion to a more critical bottleneck, early and accurate diagnosis.
What is TB Diagnosis?
Tuberculosis (TB) diagnosis involves identifying TB bacteria through sputum tests (smear microscopy, culture, or rapid molecular tests like GeneXpert), chest X-rays, and TB infection tests (skin test or IGRA blood test). Active TB, which causes symptoms like cough and fever, requires sputum analysis, while latent TB is detected by immune response tests
Why is TB diagnosis emerging as the central challenge in India’s TB elimination strategy?
- High Burden Reality: India contributes the largest share of global TB cases, making early detection a critical bottleneck.
- Diagnostic Delay: Delays in diagnosis increase transmission, worsen outcomes, and raise mortality.
- Asymptomatic Prevalence: National TB Survey shows ~50% of TB cases are asymptomatic, making symptom-based screening insufficient.
- Low Sensitivity Tools: Traditional sputum smear microscopy fails to detect drug resistance and has low sensitivity.
How has the TB diagnostic landscape evolved in the last decade?
- Technological Transition: Shift from sputum smear microscopy, molecular diagnostics (CBNAAT, TrueNat).
- Indigenous Innovation: TrueNat (2020) enabled decentralized molecular testing at primary care level.
- AI Integration: AI-enabled portable chest X-rays allow rapid screening and interpretation.
- Programmatic Expansion: NTEP deployed hundreds of portable X-ray machines under community screening drives.
- Non-Sputum Methods: Use of tongue swabs and alternative samples improves accessibility for vulnerable populations.
What structural gaps continue to limit the effectiveness of TB diagnostics?
- Access Inequality: Limited availability of molecular testing in rural and hard-to-reach areas.
- Human Resource Constraints: Dependence on trained radiologists and technicians restricts scaling.
- Turnaround Delays: Delayed reporting reduces treatment initiation efficiency.
- Pediatric TB Challenge: Children often lack sputum; diagnosis remains difficult due to low bacillary load.
- Extra-Pulmonary TB (EPTB): Accounts for ~25% of TB burden; diagnosis remains complex and expensive.
Why is a comprehensive diagnostic toolbox necessary for TB elimination?
- Diverse Disease Manifestation: TB presents in multiple forms (pulmonary, extra-pulmonary, asymptomatic).
- Population Diversity: Requires tools adaptable for children, elderly, and immunocompromised individuals.
- Drug Resistance Detection: Molecular tools enable early identification of resistant strains.
- Precision Targeting: AI and biomarkers help identify high-risk individuals for preventive therapy (TPT).
What role do innovation and research play in strengthening TB diagnostics?
- Evidence-Based Procurement: Technologies evaluated by ICMR before scale-up.
- Cost-Effectiveness Focus: Need for affordable and scalable diagnostic tools.
- Biomarker Development: Enables prediction of disease progression and targeted interventions.
- AI-Based Solutions: Portable ultrasound and AI-driven screening tools under development.
- Real-World Validation: Need for field-based studies to assess performance in low-resource settings.
How do community-led initiatives like TB Champions strengthen the TB response?
- Peer Advocacy: TB survivors act as communicators, reducing stigma and improving awareness.
- Behavioural Change: Community engagement improves treatment adherence and early reporting.
- The National Tuberculosis Elimination Programme (NTEP) Integration: Survivor-led model formally adopted under National TB Elimination Programme.
- Social Inclusion: Targets vulnerable groups, urban poor, tribal populations, socially marginalized.
- Anti-Stigma Impact: Increased confidence among patients; improved care-seeking behaviour.
Conclusion
India’s TB elimination strategy is increasingly dependent on diagnostic transformation rather than treatment expansion. While technological innovation and community participation have improved detection capacity, systemic gaps in accessibility, inclusivity, and real-world implementation persist. A comprehensive, evidence-based, and decentralized diagnostic ecosystem is essential to accelerate progress toward TB elimination.
